- Home
- GSBC vs EYPT Comparison
GSBC vs EYPT Comparison
Compare GSBC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- EYPT
- Stock Information
- Founded
- GSBC 1923
- EYPT 1987
- Country
- GSBC United States
- EYPT United States
- Employees
- GSBC N/A
- EYPT N/A
- Industry
- GSBC Major Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- GSBC Finance
- EYPT Industrials
- Exchange
- GSBC Nasdaq
- EYPT Nasdaq
- Market Cap
- GSBC 665.7M
- EYPT 579.4M
- IPO Year
- GSBC N/A
- EYPT 2005
- Fundamental
- Price
- GSBC $60.75
- EYPT $10.36
- Analyst Decision
- GSBC Hold
- EYPT Strong Buy
- Analyst Count
- GSBC 2
- EYPT 8
- Target Price
- GSBC $59.50
- EYPT $24.75
- AVG Volume (30 Days)
- GSBC 91.9K
- EYPT 811.1K
- Earning Date
- GSBC 07-16-2025
- EYPT 08-06-2025
- Dividend Yield
- GSBC 2.60%
- EYPT N/A
- EPS Growth
- GSBC 10.52
- EYPT N/A
- EPS
- GSBC 5.60
- EYPT N/A
- Revenue
- GSBC $219,572,000.00
- EYPT $56,042,000.00
- Revenue This Year
- GSBC N/A
- EYPT N/A
- Revenue Next Year
- GSBC $1.04
- EYPT N/A
- P/E Ratio
- GSBC $11.00
- EYPT N/A
- Revenue Growth
- GSBC N/A
- EYPT 12.04
- 52 Week Low
- GSBC $47.58
- EYPT $3.91
- 52 Week High
- GSBC $68.02
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- GSBC 59.19
- EYPT 61.63
- Support Level
- GSBC $61.18
- EYPT $9.45
- Resistance Level
- GSBC $62.90
- EYPT $11.69
- Average True Range (ATR)
- GSBC 1.36
- EYPT 0.83
- MACD
- GSBC 0.19
- EYPT 0.03
- Stochastic Oscillator
- GSBC 68.14
- EYPT 64.53
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.